Patents
Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828)
08/1998
08/12/1998CN1190404A Neuroactive steroids of androstane and pregnane series
08/04/1998US5789607 Process for the preparation of 1,25-dihydroxy-16-ene-23-yne-cholecalciferol
08/04/1998CA2101275C Methods for the treatment of osteoporosis
07/1998
07/30/1998WO1998032718A1 New fatty acid derivatives
07/29/1998CN1039329C Process for preparing steroid esters compound
07/29/1998CN1039328C D-high-(16-ene)-11 beta-aryl-4-estrene-3-ketonic-like compound preparing process
07/23/1998WO1998031702A1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives
07/23/1998WO1998031381A1 Compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants
07/23/1998CA2277924A1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives
07/21/1998US5783571 Method of altering hypothalamic function by nasal administration of estrene steroids
07/21/1998US5783208 Transdermal drug delivery matrix for coadministering estradiol and another steroid
07/14/1998US5780460 Therapeutic methods and delivery systems utilizing sex steroid precursors
07/07/1998US5776923 Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
07/02/1998WO1998028322A1 Bissteroidal compounds and their use for the preparation of chiral complexes
07/02/1998CA2275879A1 Bissteroidal compounds and their use for the preparation of chiral complexes
06/1998
06/24/1998EP0849274A1 Bissteroidal compounds and their use for the preparation of chiral complexes
06/24/1998EP0848620A1 Agent, for transdermal application, containing esters of 3-ketodesogestrel
06/23/1998US5770729 Sulfide compound with polar substituents, formation of sulfoxide, mild conditions, safe, nonpolluting
06/23/1998CA1339924C 11beta-phenyl-14betha steroids
06/18/1998WO1998025948A2 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein
06/18/1998CA2550897A1 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein
06/11/1998WO1998024448A1 METHOD OF PREVENTING NEURODEGENERATION AND COGNITIVE DYSFUNCTION USING 17α-DIHYDROEQUILENIN
06/11/1998CA2272891A1 Method of preventing neurodegeneration and cognitive dysfunction using 17.alpha.-dihydroequilenin
06/10/1998DE19723390C1 New 9-alpha-hydroxy-8-alpha-oestratriene derivatives
06/09/1998US5763433 Pharmaceutical compositions containing 3-beta-hydroxylated 6,7-substituted steroid derivatives, and use thereof
06/02/1998US5760255 Reacting with perfluoroalkylsulfonyl fluoride in presence of strong organic base in inert organic solvent
06/02/1998US5760046 oral low daily dosage of FINASTERIDE; treating female hirsutism; promoting hair growth; hyperandrogenic conditions of acne vulgaris, seborrhea, polycystic ovary syndrome
06/02/1998US5760025 Administering testosterone 5a-reductase inhibitors
05/1998
05/26/1998US5756490 Estrogen and gestagen
05/20/1998CN1182368A Immanomodulating compositions from bile for treatment of immune system disorders
05/06/1998CN1181077A Benzopyran-containing compounds and method for their use
04/1998
04/29/1998EP0837874A2 Neuroactive steroids of the androstane and pregnane series
04/28/1998US5744462 Administering glucose-6-phosphate dehydrogenase inhibitor
04/23/1998WO1998016544A1 8(9)-dehydroestradiol derivatives
04/23/1998WO1998016543A1 Remedy for chronic fatigue syndrome
04/23/1998CA2268330A1 8(9)-dehydroestradiol derivatives
04/22/1998EP0429480B1 Natriuretic hormone
04/21/1998US5741786 Steroids with a 17-spiromethylene lactone or lactol group
04/16/1998WO1998015279A1 Hormonal composition consisting of an oestrogen compound and of a progestational compound
04/15/1998EP0835113A1 Dehydroepiandrosterone derivatives for preventing progressive tissue necrosis reperfusion injury, bacterial translocation and adult respiratory distress syndrome
04/14/1998US5739363 Using lithium salt of ethylenediamine or lithium amide in dimethyl sulfoxide
04/14/1998US5739302 Subjecting acetoxyestrogen to fries rearrangement in presence of acetyl chloride, using dakin reaction to replace acetyl group with hydroxyl group at alkaline ph
04/14/1998US5739125 Used to induce abortion or labor, or to treat endometrosis, dysmenorrhea, or progestin hormone-dependent tumors
04/07/1998US5736537 Dehydroep:androsterone sailcylate useful against skin atrophy
04/01/1998EP0716599B1 TRANSDERMAL THERAPEUTIC SYSTEM FOR THE RELEASE OF 17-$g(b)-ESTRADIOL AND PROCESS FOR ITS PRODUCTION
04/01/1998EP0572451B1 Novel steroid esters
03/1998
03/19/1998WO1998011123A1 Carbamate-derivatized nucleosides and oligonucleosides
03/18/1998EP0829263A1 Use of 8,9-dehydroestrone in estrogen therapy
03/18/1998CN1037769C Process for extracting vitamin E and sterol from by-product after refining vegetable oil
03/17/1998US5728689 11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
03/17/1998US5728688 Therapeutic methods and delivery systems utilizing sex steroid precursors
03/16/1998CA2215655A1 Use of 8,9-dehydroestrone as an estrogen with neutral effects on prolactin levels
03/12/1998WO1998005679A3 Mixed agonists of the progesterone receptor and assays therefor
03/11/1998CN1175903A Method of treating adenosine depletion
03/10/1998US5725840 Steroidal ester contrast media for x-ray and magnetic resonance imaging
03/04/1998EP0700293B1 Dihydrotestosterone for use in androgenotherapy
03/03/1998US5723455 Contraceptives
03/03/1998US5723454 Membrane filtration using adsoorber resin, washing with water and elution liquid, desorption with ether, alcohol or ketone
02/1998
02/25/1998EP0825197A2 New 6-hydroxy and 6-oxo-anstro-stane derivatives active on the cardiovascular system and pharmaceutical compositions containing same
02/25/1998EP0824346A2 Use of sesquiterpenes for inhibiting oxidative enzymes
02/24/1998US5721227 17-aryl and 17-heterocyclyl-14β-5α-androstane, androstene and androstadiene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
02/24/1998CA2086919C Process for the production of unsaturated 17.alpha.-cyanomethyl -17.beta. hydroxy steroids
02/18/1998EP0823897A1 Nicotinic acid esters and pharmaceutical compositions containing them
02/18/1998EP0823895A1 Fatty acid esters as bioactive compounds
02/18/1998EP0823889A1 1,3-propane diol derivatives as bioactive compounds
02/17/1998US5719300 Process for the preparation of gestodene
02/17/1998US5719137 Method of preventing neurodegeneration and cognitive dysfunction using 17α-dihydroequilenin
02/12/1998WO1998005679A2 Mixed agonists of the progesterone receptor and assays therefor
02/10/1998US5717088 Method of making steroid derivatives for the treatment of prostatic hypertrophy
02/05/1998WO1998004577A1 PROCESS FOR PREPARING 16α-HYDROXY-ESTRA-1,3,5(10)-TRIENE DERIVATIVES
02/05/1998CA2260121A1 Process for preparing 16.alpha.-hydroxy-estra-1,3,5(10)-triene derivatives
02/04/1998EP0655916B1 Transdermal application agent containing 3-keto-desogestrel
02/03/1998US5714481 Administering to mammalian host a glucose-6-phsophate dehydrogenase inhibitor, anticarcinogenic, antiobasity, anti-hyperglycemic, antiaging, anticholesterol and anti-autoimmune agent
01/1998
01/29/1998WO1998003137A1 Transdermal drug delivery matrix for coadministering estradiol and another steroid
01/22/1998WO1998002450A2 6,7-oxygenated steroids and uses related thereto
01/20/1998US5710144 Osteoporosis
01/20/1998US5709881 Tablet capsule or granule comprising desogestrel
01/15/1998DE19626400A1 1,4-Addition of alkyl to unsaturated carbonyl compound
01/14/1998EP0684825A4 Method of preventing or inhibiting fertilization.
01/14/1998CN1170353A Intravaginal drug delivery devices for the administration fo 17 'beta'-oestradiol precursors
01/07/1998EP0814821A1 Immunomodulating compositions from bile for the treatment of immune system disorders
01/06/1998US5705494 Anti-estrogenic activity of IIβ-substituted-19-NOR Steroids
01/06/1998US5705335 Design of drugs involving receptor-ligand-DNA interactions
12/1997
12/31/1997WO1997049407A1 Progestogen-anti-progestogen regimens
12/31/1997CN1168876A Method for prepn. of steroid derivative ketal
12/31/1997CN1036835C Method for prepn. of multiple step combination type contraceptive
12/31/1997CN1036833C Method for prepn. of multiple step contraceptive
12/31/1997CA2255863A1 Progestogen-anti-progestogen regimens
12/23/1997US5700793 An androstane-17-one and ene steroids; hypoglycemic agent, anticholesterol agent; treating autoimmune diseases
12/10/1997EP0811006A1 Benzopyran-containing compounds and method for their use
12/10/1997EP0810863A1 Method of treating adenosine depletion
12/10/1997CN1167489A Novel estrenes for inducing hypothalamic effects
12/09/1997US5696107 Administering androsten-3-ol
12/09/1997US5696106 Steroids useful as anti-cancer and anti-obesity agents
12/09/1997CA1339570C New 11-aryl steroid derivatives
12/04/1997WO1997045441A1 7α-(5-METHYLAMINOPENTYL)-ESTRATRIENES, PROCESS FOR THE PREPARATION THEREOF, PHARMACEUTICAL PREPARATIONS WHICH CONTAIN SAID 7α-(5-METHYLAMINOPENTYL)-ESTRATRIENES AND USE THEREOF FOR PRODUCTION OF DRUGS
12/04/1997WO1997037664A3 Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
12/04/1997CA2256344A1 7.alpha.-(5-methylaminopentyl)-estratrienes, process for their production, pharmaceutical preparations that contain these 7.alpha.-(5-methylaminopentyl)-estratrienes as well as their use for the production of pharmaceutical agents
12/03/1997CN1166836A Novel androstanes with inducing hypothalamic effects
12/03/1997CN1036591C Carbamates of repamycin
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 49